NCT02780414 Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers Status COMPLETED Phase N/A
NCT02718716 Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia Status COMPLETED Phase PHASE2
NCT02707497 The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia Status RECRUITING Phase PHASE2/PHASE3
NCT02679443 Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy Status COMPLETED Phase NA
NCT02530515 Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT02487563 Prospective Study of Patients With Thrombocytopenia Following HSCT Status COMPLETED Phase PHASE3
NCT02444728 Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE Status TERMINATED Phase PHASE3
NCT02389621 Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures Status COMPLETED Phase PHASE3
NCT02371330 The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study Status COMPLETED Phase N/A
NCT02344979 The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC Status UNKNOWN Phase N/A
NCT02323178 A Study of Eltrombopag in Patients With CMML and Thrombocytopenia Status COMPLETED Phase PHASE1/PHASE2
NCT02298933 Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia Status COMPLETED Phase PHASE2
NCT02276651 Observational Trial of a Therapeutic Platelet Transfusion Regimen Status TERMINATED Phase N/A
NCT02267993 Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients Status COMPLETED Phase PHASE4
NCT02263157 Evaluate the Association Between Infection and Thrombocytopenia Status COMPLETED Phase N/A
NCT02244658 Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia Status UNKNOWN Phase PHASE3
NCT02241031 Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia Status UNKNOWN Phase PHASE2/PHASE3